Susceptibility-guided quadruple therapy is not superior to medication history-guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial.
Chao Ran JiJing LiuYue Yue LiChen QiaoJun Yan QuJun Nan HuMin Juan LinRui JiLi Xiang LiXiu-Li ZuoYan Qing LiPublished in: Journal of digestive diseases (2020)
AST-guided therapy was not superior to PMH-guided therapy as a second- or third-line treatment for H. pylori infection. Considering the cost-effectiveness, PMH therapy is clinically more favorable.